Molecular Landscape of Non-Muscle Invasive Bladder Cancer

Joshua J Meeks, Seth P. Lerner*

*Corresponding author for this work

Research output: Contribution to journalShort survey

5 Citations (Scopus)

Abstract

In this issue of Cancer Cell, Hurst et al. report an integrated analysis of non-invasive (stage Ta) bladder cancer. Two genomic subtypes are distinguished by chromosome 9q loss, resulting in increased AKT/PI3K/mTOR signaling. Tumors from female patients have a higher frequency of KDM6A mutations. In this issue of Cancer Cell, Hurst et al. report an integrated analysis of non-invasive (stage Ta) bladder cancer. Two genomic subtypes are distinguished by chromosome 9q loss, resulting in increased AKT/PI3K/mTOR signaling and increased risk of recurrence. Tumors from female patients have a higher frequency of KDM6A mutations.

Original languageEnglish (US)
Pages (from-to)550-551
Number of pages2
JournalCancer Cell
Volume32
Issue number5
DOIs
StatePublished - Nov 13 2017

Fingerprint

Urinary Bladder Neoplasms
Mutation Rate
Phosphatidylinositol 3-Kinases
Neoplasms
Chromosomes
Recurrence

ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research

Cite this

Meeks, Joshua J ; Lerner, Seth P. / Molecular Landscape of Non-Muscle Invasive Bladder Cancer. In: Cancer Cell. 2017 ; Vol. 32, No. 5. pp. 550-551.
@article{8ddb607e70df4b69ae43f11d80ce03ae,
title = "Molecular Landscape of Non-Muscle Invasive Bladder Cancer",
abstract = "In this issue of Cancer Cell, Hurst et al. report an integrated analysis of non-invasive (stage Ta) bladder cancer. Two genomic subtypes are distinguished by chromosome 9q loss, resulting in increased AKT/PI3K/mTOR signaling. Tumors from female patients have a higher frequency of KDM6A mutations. In this issue of Cancer Cell, Hurst et al. report an integrated analysis of non-invasive (stage Ta) bladder cancer. Two genomic subtypes are distinguished by chromosome 9q loss, resulting in increased AKT/PI3K/mTOR signaling and increased risk of recurrence. Tumors from female patients have a higher frequency of KDM6A mutations.",
author = "Meeks, {Joshua J} and Lerner, {Seth P.}",
year = "2017",
month = "11",
day = "13",
doi = "10.1016/j.ccell.2017.08.015",
language = "English (US)",
volume = "32",
pages = "550--551",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "5",

}

Molecular Landscape of Non-Muscle Invasive Bladder Cancer. / Meeks, Joshua J; Lerner, Seth P.

In: Cancer Cell, Vol. 32, No. 5, 13.11.2017, p. 550-551.

Research output: Contribution to journalShort survey

TY - JOUR

T1 - Molecular Landscape of Non-Muscle Invasive Bladder Cancer

AU - Meeks, Joshua J

AU - Lerner, Seth P.

PY - 2017/11/13

Y1 - 2017/11/13

N2 - In this issue of Cancer Cell, Hurst et al. report an integrated analysis of non-invasive (stage Ta) bladder cancer. Two genomic subtypes are distinguished by chromosome 9q loss, resulting in increased AKT/PI3K/mTOR signaling. Tumors from female patients have a higher frequency of KDM6A mutations. In this issue of Cancer Cell, Hurst et al. report an integrated analysis of non-invasive (stage Ta) bladder cancer. Two genomic subtypes are distinguished by chromosome 9q loss, resulting in increased AKT/PI3K/mTOR signaling and increased risk of recurrence. Tumors from female patients have a higher frequency of KDM6A mutations.

AB - In this issue of Cancer Cell, Hurst et al. report an integrated analysis of non-invasive (stage Ta) bladder cancer. Two genomic subtypes are distinguished by chromosome 9q loss, resulting in increased AKT/PI3K/mTOR signaling. Tumors from female patients have a higher frequency of KDM6A mutations. In this issue of Cancer Cell, Hurst et al. report an integrated analysis of non-invasive (stage Ta) bladder cancer. Two genomic subtypes are distinguished by chromosome 9q loss, resulting in increased AKT/PI3K/mTOR signaling and increased risk of recurrence. Tumors from female patients have a higher frequency of KDM6A mutations.

UR - http://www.scopus.com/inward/record.url?scp=85033667156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033667156&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2017.08.015

DO - 10.1016/j.ccell.2017.08.015

M3 - Short survey

C2 - 29136502

AN - SCOPUS:85033667156

VL - 32

SP - 550

EP - 551

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 5

ER -